AZTA azenta.com: Multiplikator Forward P/S

Reduced capital expenditures by biotech laboratories are weighing on sales, which is reflected in the forward P/S dynamics based on forecasts on the GURU.Markets chart, where the value 3.10 shows the current figure. High barriers to entry and minimal customer churn ensure the stability of Azenta, Inc. (AZTA). Meanwhile, the implementation of cryogenic robotics for the protection of genetic materials positions the company as the core infrastructure of modern cellular medicine.

azenta.com - Rasio kapitalisasi marang dodolan sing dikarepake AZTA (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Brooks Automation (AZTA)

- rega saiki lan proyeksi nilai saham:

Rega saham Azenta|AZTA - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Brooks Automation|AZTA - Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham Azenta|AZTA - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku azenta.com|AZTA - Gunggung Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

- rincian asil keuangan lan kelipatan valuasi:

AZTA - Bathi resik taunan|Bathi mangsa ngarep Azenta, Inc.|AZTA - Pangali P/E|Pangali Forward P/E Azenta Life Sciences|AZTA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Brooks Automation|AZTA - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Azenta|AZTA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan azenta.com|AZTA - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Azenta, Inc.

- indikator volume dodolan lan pendapatan:

AZTA - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Azenta|AZTA - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Brooks Automation

Ringkesan analitik perusahaan:Azenta (AZTA)

Logistics optimization for cryogenic equipment at Azenta, Inc. (AZTA) directly impacts the company's forward P/S dynamics. This indicator correlates current market capitalization with expected future sales volume, determining the premium paid for future growth. The calculation is based on projected revenue, allowing for an assessment of the business's fundamental margin of safety. The stability of this ratio confirms capital resilience and the adequacy of market expectations.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Varex Imaging Corp (VREX)|Multiplikator Forward P/S SMLR|Multiplikator Forward P/S Butterfly Corp (BFLY)|Rasio rega marang prakiraan pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)